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The Zingiberaceae family is found in tropical and subtropical areas, with approximately 161 species 
from 18 genera of this family found in Peninsular Malaysia. Zingiber zerumbet (L.) Smith tree 
belonging to this family is an edible ginger, originating in South-East Asia, and has been cultivated 
for thousands of years as a spice and for medical purposes. The aim of this study is to isolate the 
active principle from extracted essential oil of fresh Zingiber Zerumbet rhizomes by steam-
hydrodistillation method. In addition, to determine the purity of this active compound using validated 
reverse phase high performance liquid chromatography (RP-HPLC). Moreover, the antiproliferative 
effects of this active principal on various human cancerous and noncancerous cell lines at 
concentrations of 1 to 100 μg/mL were quantified by MTT assay. As a result, colorless zerumbone 
(ZER) crystals about 1.3 g/kg as an active principal were extracted from the essential oil of fresh Z. 
Zerumbet rhizomes. The purity of ZER crystals were shown to be (99.96%). Simultaneously, ZER 
exhibited significant (P < 0.05) inhibitory effects towards various human cancerous cell lines, while 
not affected noncancerous cell lines. In conclusion, ZER is suggested to be further developed into a 
safe therapeutic compound for the treatment of various human cancers. 
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